Literature DB >> 6254839

Construction and characterization of a bacterial clone containing the hemagglutinin gene of the WSN strain (HON1) of influenza virus.

A R Davis, A L Hiti, D P Nayak.   

Abstract

A synthetic dodecadeoxynucleotide primer has been used to prepare a double-stranded DNA form of the hemagglutinin (HA) gene of a human influenza virus (WSN strain, HON1). This DNA has been inserted in plasmid pBR322 and cloned in bacterial cells. The insert contains nearly the complete hemagglutinin gene. A restriction map of this insert has been determined and structurally important areas of the HA gene have been sequenced. Amino acid sequences of several regions of the HA protein were deduced from the DNA sequences and compared to the known amino acid sequences of other influenza A viruses. WSN HA shows extensive homology to all influenza A viruses in a few regions, namely the first 17 amino acids of the N-terminus of HA1 (N-terminal polypeptide of HA) and the first 24 amino acids of the N-terminus of HA2 (C-terminal polypeptide of HA). The sequence diverges extensively from other influenza A viruses in most other areas. The sequence of WSN virus HA is similar to that of other HON1 viruses with the exception of the C-terminus of the HA1 peptide. The change in this area may contribute to some of the unique properties of WSN virus among the HON1 viruses. In addition, WSN HA contains a 17-amino-acid precursor before the N-terminus of HA1 and a single amino acid, arginine, connecting HA1 and HA2.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6254839     DOI: 10.1016/0378-1119(80)90050-5

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  11 in total

1.  Expression of antigenic determinants of the hemagglutinin gene of a human influenza virus in Escherichia coli.

Authors:  A R Davis; D P Nayak; M Ueda; A L Hiti; D Dowbenko; D G Kleid
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

2.  Complete sequence analyses show that two defective interfering influenza viral RNAs contain a single internal deletion of a polymerase gene.

Authors:  D P Nayak; N Sivasubramanian; A R Davis; R Cortini; J Sung
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

3.  Sequence analysis of the polymerase 1 gene and the secondary structure prediction of polymerase 1 protein of human influenza virus A/WSN/33.

Authors:  N Sivasubramanian; D P Nayak
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

4.  Influenza viral (A/WSN/33) hemagglutinin is expressed and glycosylated in the yeast Saccharomyces cerevisiae.

Authors:  M A Jabbar; N Sivasubramanian; D P Nayak
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

5.  Complete nucleotide sequence of the polymerase 3 gene of human influenza virus A/WSN/33.

Authors:  J S Kaptein; D P Nayak
Journal:  J Virol       Date:  1982-04       Impact factor: 5.103

6.  NH2-terminal hydrophobic region of influenza virus neuraminidase provides the signal function in translocation.

Authors:  T J Bos; A R Davis; D P Nayak
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

7.  Human influenza virus hemagglutinin is expressed in monkey cells using simian virus 40 vectors.

Authors:  J R Hartman; D P Nayak; G C Fareed
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

8.  Influenza virus gene expression: control mechanisms at early and late times of infection and nuclear-cytoplasmic transport of virus-specific RNAs.

Authors:  G I Shapiro; T Gurney; R M Krug
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

9.  Complete nucleotide sequence of the nucleoprotein gene of influenza B virus.

Authors:  D R Londo; A R Davis; D P Nayak
Journal:  J Virol       Date:  1983-09       Impact factor: 5.103

10.  Complete nucleotide sequence of the neuraminidase gene of human influenza virus A/WSN/33.

Authors:  A L Hiti; D P Nayak
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.